Skip to main content
SpringerLink
Log in

Middle-aged heterozygous carriers of Wilson’s disease do not present with significant phenotypic deviations related to copper metabolism

  • Research Note
  • Published:
Journal of Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Ala A., Walker A. P., Ashkan K., Dooley J. S. and Schilsky M. L. 2007 Wilson’s disease. Lancet 69, 397–408.

    Article  Google Scholar 

  • Barbosa E. R., Machado A. A., Cancádo E. L., Deguti M. M. and Scaff M. 2009 Wilson’s disease: a case report and a historical review. Arq. Neuropsiquiatr 67, 539–543.

    Article  PubMed  Google Scholar 

  • Benito-León J. 2009 How common is essential tremor? Neuroepidemiology 32, 215–216.

    Article  PubMed  Google Scholar 

  • Cartwright G. E., Markowitz H., Shields G. S. and Wintrobe M. M. 1960 Studies on copper metabolism. XXIX. A. Critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson’s disease and relatives of patients with Wilson’s disease. Am. J. Med. 28, 555–563.

    Article  PubMed  CAS  Google Scholar 

  • Cater M. A., La Fontaine S. and Mercer J. F. 2007 Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B). Biochem. J. 401, 143–153.

    Article  PubMed  CAS  Google Scholar 

  • Cox D.W., Fraser F. C. and Sass-Kortsak A. 1972 A genetic study of Wilson’s disease: evidence for heterogeneity. Am. J. Hum. Genet. 24, 646–666.

    PubMed  CAS  Google Scholar 

  • Das S. K. and Ray K. 2006 Wilson’s disease: an update. Nat. Clin. Pract. Neurol. 2, 482–493.

    Article  PubMed  Google Scholar 

  • de Bie P., Muller P., Wijmenga C. and Klomp L.W. 2007 Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J. Med. Genet. 44, 673–688.

    Article  PubMed  Google Scholar 

  • Forbes J. R. and Cox D. W. 2000 Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. Hum. Mol. Genet. 9, 1927–1935.

    Article  PubMed  CAS  Google Scholar 

  • Gromadzka G., Schmidt H. H., Genschel J., Bochow B., Rodo M., Tarnacka B. et al. 2005 Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease. Clin. Genet. 68, 524–532.

    Article  PubMed  CAS  Google Scholar 

  • Gromadzka G., Schmidt H. H., Genschel J., Bochow B., Rodo M., Tarnacka B. et al. 2006 p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson’s disease. Mov. Disorders 21, 245–248.

    Article  Google Scholar 

  • Haghighat M., Dehghani S. M., Imanieh M. H. and Gholami S. 2008 Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson’s disease. Saudi Med. J. 29, 1056–1057.

    PubMed  Google Scholar 

  • Heuyer G., Baudoin A., Azima H., Faure H., Jerome H. and Schmitt H. 1953 Considerations onWilson’s disease; genealogic, clinical, and metabolic investigations on 60 members of one family. Rev. Neurol. (Paris) 89, 165–181.

    CAS  Google Scholar 

  • Huster D., Hoppert M., Lutsenko S., Zinke J., Lehmann C., Mössner J. et al. 2003 Defective cellular localization of mutant ATP7B in Wilson’s disease patients and hepatoma cell lines. Gastroenterology 124, 335–345.

    Article  PubMed  CAS  Google Scholar 

  • Johnson S. 2001 Is Parkinson’s disease the heterozygote form of Wilson’s disease: PD = 1/2 WD? Med. Hypotheses 56, 171–173.

    Article  PubMed  CAS  Google Scholar 

  • Neale F. C. and Fischer-Williams M. 1958 Copper metabolism in normal adults and in clinically normal relatives of patients with Wilson’s disease. J. Clin. Pathol. 11, 441–447.

    Article  PubMed  CAS  Google Scholar 

  • Nevsímalová S., Marecek Z. and Roth B. 1986 An EEG study of Wilson’s disease. Findings in patients and heterozygous relatives. Electroencephalogr. Clin. Neurophysiol. 64, 191–198.

    Article  PubMed  Google Scholar 

  • Nicholl D. J., Ferenci P., Polli C., Burdon M. B. and Pall H. S. 2001 Wilson’s disease presenting in a family with an apparent dominant history of tremor. J. Neurol. Neurosurg. Psychiatry 70, 514–516.

    Article  PubMed  CAS  Google Scholar 

  • Petrukhin K., Lutsenko S., Chernov I., Ross B.M., Kaplan J. H. and Gilliam T. C. 1994 Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum. Mol. Genet. 3, 1647–1656.

    Article  PubMed  CAS  Google Scholar 

  • Quinn N. P. and Marsden C. D. 1986 Coincidence of Wilson’s disease with other movement disorders in the same family. J. Neurol. Neurosurg. Psychiatry 49, 221–222.

    Article  PubMed  CAS  Google Scholar 

  • Ravin H. A. 1961 An improved colorimetric assay of ceruloplasmin. J. Lab. Clin. Med. 61, 161–168.

    Google Scholar 

  • Sternlieb I., Morell A. G., Bauer C. D., Combes B., De Bobes-Sternberg S. and Schein-Berg I. H. 1961 Detection of the heterozygous carrier of the Wilson’s disease gene. J. Clin. Invest. 40, 707–715.

    Article  CAS  Google Scholar 

  • Tarnacka B., Szeszkowski W., Buettner J., Golebiowski M., Gromadzka G. and Czlonkowska A. 2009 Heterozygous carriers for Wilsons disease magnetic spectroscopy changes in the brain. Metab. Brain Dis. 24, 463–468.

    Article  PubMed  CAS  Google Scholar 

  • Tórsdóttir G., Gudmundsson G., Kristinsson J., Snaedal J. and Jóhannesson T. 2009 Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study. Neuropsychiatr. Dis. Treat. 5, 55–59.

    Article  PubMed  Google Scholar 

  • Vrabelova S., Letocha O., Borsky M. and Kozak L. 2005 Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients withWilson disease. Mol. Genet. Metab. 86, 277–285.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Neurology, Institute of Psychiatry and Neurology, 02-957, Warsaw, Poland

    G. Gromadzka, G. Chabik, T. Mendel, A. Wierzchowska & A. Czlonkowska

  2. Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 00-325, Warsaw, Poland

    G. Gromadzka, M. Rudnicka & A. Czlonkowska

Authors
  1. G. Gromadzka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Chabik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Mendel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Wierzchowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Rudnicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Czlonkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to G. Gromadzka or A. Czlonkowska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gromadzka, G., Chabik, G., Mendel, T. et al. Middle-aged heterozygous carriers of Wilson’s disease do not present with significant phenotypic deviations related to copper metabolism. J Genet 89, 463 (2010). https://doi.org/10.1007/s12041-010-0065-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12041-010-0065-3

Keywords

Search

Navigation